Fiji vs Togo: Treatment success rate for patients treated for MDR-TB
Fiji
60.0%
in 2022
Togo
60.0%
in 2022
Fiji rank
120th
Togo rank
120th
Treatment success rate for patients treated for MDR-TB over time
- Fiji
- Togo
How they compare
Fiji currently reports 60.0% against 60.0% in Togo, a difference of 0.0%.
The two have swapped places 2 times across 6 shared years of data; in 2014 it was Togo ahead.
Fiji ranks 120th and Togo ranks 120th of 163 countries.
Fiji has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Fiji | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 88.5% | 11.5% | Fiji |
| 2020s | 67.5% | 59.0% | 8.5% | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Fiji or Togo?
- Fiji, at 60.0% against 60.0% in Togo as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Fiji and Togo?
- 0.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Togo?
- 6 years are reported by both, from 2014 to 2022.
- How do Fiji and Togo rank globally for treatment success rate for patients treated for mdr-tb?
- Fiji ranks 120th and Togo ranks 120th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.